Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)

Ramos-Casals, M.; Maria, A.; Suarez-Almazor, M.; Lambotte, O.; Fisher, B.; Hernandez-Molina, G.; Guilpain, P.; Pundole, X.; Flores-Chavez, A.; Baldini, C.; Bingham, C.; Brito-Zeron, P.; Gottenberg, J.; Kostine, M.; Radstake, T.; Schaeverbeke, T.; Schulze-Koops, H.; Calabrese, L.; Khamashta, M.; Mariette, X.; Kostov, Belchin; Calabrese, Cassandra; Retamozo, Soledad; Ma Aguilar, Eva; Richter, Michael; Lidar, Merav; Fisher, Ben; Michot, Jean; Liew, David; Heiberg, Marte; Danda, Debashish; Olsson, Peter; Suzuki, Yasunori; Citera, Gustavo; Kawano, Mitsuhiro; KILIÇKAP, SAADETTİN; Arrieta, Oscar; Moca Trevisani, Virginia; Praprotnik, Sonja; Horvath, Ildiko; Azuma, Naoto

Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)

Ramos-Casals M., Maria A., Suarez-Almazor M. E., Lambotte O., Fisher B. A., Hernandez-Molina G., ...More

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.37, no.3, 2019 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 37 Issue: 3
Publication Date: 2019
Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe University Affiliated: Yes

Abstract

Objectives: To analyse the worldwide occurrence of sicca/Sjogren's (SS) syndrome associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer.